Bought-deal underwriting

Have investors ever wondered how companies quickly raise funds without a lengthy process?  Companies may swiftly raise capital by selling all their shares to an underwriter known as bought-deal underwriting. Investors may then acquire these securities via the broker, and companies that need cash quickly for various reasons must adopt this strategy.  

Bought-deal underwriting saves companies time and risk in public bids. It ensures they immediately obtain the cash they need, but the investor risks selling the company’s equity. Thus, companies may quickly and easily receive the financing they need to succeed. 

What is bought-deal underwriting? 

Bought-deal underwriting is a financial process where an underwriter, typically an investment bank, buys an entire issuance of securities directly from the issuer before they are made available to the public. When an underwriter pledges to acquire all equities at a specified price, they assume risk and gain the most from underwriting-bought deals. 

The underwriter assumes the market risk, and if the market is active, the investors may get a profit. Underwriters who need money rapidly without conventional public offerings’ risk and time commitment are most likely to employ this strategy.  

Understanding bought-deal underwriting 

In a bought-deal underwriting, the underwriter agrees to purchase the entire issue of securities from the issuer, ensuring that the issuer receives immediate funds. Market conditions and investors’ interests determine public auction success because the underwriter bears market change risk, and they understand the market and investor behaviour to make wise decisions.  

Underwriters can better predict whether the securities will be offered to investors again, and bought deal underwriting is typically underwritten in a few days. Most public offerings take weeks or months to complete because underwriters need a lot of marketing, and this short turnaround is significant since it’s distinct from typical public offers.  

Underwriters may earn more money if they analyse the market and trade equities at a fair price. However, underwriters might lose money if market circumstances worsen after the sale because they risk losing money. 

Advantages of bought-deal underwriting 

  • Rapid access to capital 

Bought deal underwriting helps companies receive capital rapidly, and many companies that need money rapidly to buy, develop, or invest in critical initiatives require this bought deal. When underwriters need to move swiftly to take advantage of market opportunities or satisfy urgent financial responsibilities, the rapid return may assist. 

  • Financing assurance 

One of the most significant advantages of bought-deal underwriters is the financing assurance guarantee that money will be there when required. Companies may acquire the money they need regardless of market conditions or investors’ interests, and this assurance removes the uncertainties associated with public offers.  

  • Reduced market risk for issuers 

When issuers sign bought-deal agreements, the underwriters assume market risk and market fluctuations. Issuers don’t need to worry about how market circumstances can influence their securities’ prices or interest rates. This decreased market risk calms purchasers during significant volatility or long-term economic uncertainty. 

  • Efficiency in fundraising 

The bought-deal process is highly efficient, typically concluding within a few days. Due to marketing, regulatory clearances, and roadshows, a conventional public offering might take weeks or months. Bought-deal underwriting is so simple that companies can concentrate on their strengths without spending time in fundraising activities. 

  • Potential for underwriter profit 

For underwriters, bought-deal underwriting presents an opportunity for significant profits. The underwriter may resell the equities at a higher price, making much money, and this is achievable if the insurer accurately estimates market demand. The investors must know how the market works to reduce the hazards of this earning opportunity. 

Usage of bought-deal underwriting 

  • Technology sector 

The technology sector employs bought-deal underwriting because the market changes swiftly. Due to rapid technical and product development, companies require money to keep ahead of competitors, and the technology sector requires fast funding for research and development. 

  • Biotechnology industry 

The biotechnology sector frequently uses bought-deal underwriting because of the industry’s inherent volatility and the significant capital required for research and development.  Most biotechnology industries require a lot of money to launch novel drugs or treatments, which saves money for health research.  

  • Energy sector 

Energy sector may change swiftly due to price fluctuations or industry regulations. Bought deal underwriting funds large construction projects or capitalises on market circumstances. Energy sectors utilise this to raise funds so companies can better adapt to shifting situations and seize opportunities when they can access money rapidly. 

  • Expanding operations 

Bought-deal underwriting helps growing companies acquire funding rapidly, which allows them to expand. Insurance funds growth in bought-deal underwriting at the proper moment, and these growth efforts include opening new markets, introducing new products, and creating additional storefronts. 

  • Debt refinancing 

Bought-deal underwriting helps companies restructure debt. This technique lets a company sell new stocks to pay off debt or improve its terms. This will improve the company’s finances, and interest rates may drop. 

Examples of bought-deal underwriting 

Suppose XYZ LTD plans to launch its shares as a fresh issue in the equity market. However, they worry about market changes and share purchases. Due to a purchase agreement, the company is selling its shares, and the credit Investment company would acquire the whole land.

Due to this, XYZ Ltd. sold all its shares to Credit Investments for 120 million shares. Here, the underwriter will purchase the shares at a discounted rate to cover losses. The deal value was US$ 10; the deal would be US$ 840 million (US$ 7 by 120 million).  After a while, underwriters may acquire these shares on the secondary market. 

Frequently Asked Questions

In traditional underwriting, the underwriter does not pledge to acquire the shares immediately, and they claim to sell equities on a best-effort basis, which indicates they will do everything necessary to sell as many shares as possible at the agreed-upon price. However, bought-deal underwriters acquire the whole offering from the underwriter before selling it to the public, and the underwriter provides the seller with immediate cash and takes the risk of selling the shares in this sort of underwriting. 

In bought-deal underwriting, the underwriter plays a crucial role. The underwriter examines the market, determines the fair price for the shares, and promises to acquire wholesale from the seller. The underwriter must have the proper skills and market knowledge to sell the assets again for a profit, and the insurance company must advise investors on when and what to offer. 

Bought-deal Underwriting is rapid because the issuers enjoy several benefits over other Underwriting. Issuers get the money straight quickly, which is helpful for urgent tasks or possibilities. A regular public offering protects the seller from market movements that might impact their share price. Additionally, bought-deal underwriting can be without marketing efforts as it helps the issuer’s company’s procedures, which is good. 

The primary risk in bought-deal underwriting lies with the underwriter, as they need to be able to resell the items at the agreed-upon price. Underwriters might lose money if the market turns sour after the transaction. Even if the underwriter offers the insurer the risk, they may obtain a lower share price than traditional Underwriting.  

Bought-deal underwritings are regulated by financial authorities to ensure transparency and protect investors. For example, the UK Financial Conduct Authority (FCA) monitors these arrangements to ensure they comply with existing laws and fair market practices. Underwriters must research equities to ensure fair pricing and provide investors with all the required information. 

  

Related Terms

    Read the Latest Market Journal

    Recognising Biases in Investing and Tips to Avoid Them

    Published on Sep 4, 2025 127 

    Common biases like overconfidence, herd mentality, and loss aversion influence both risk assessment and decision-making....

    What is Money Dysmorphia and How to Overcome it?

    Published on Sep 4, 2025 63 

    Money dysmorphia happens when the way you feel about your finances doesn’t match the reality...

    The Employer’s Guide to Domestic Helper Insurance

    Published on Sep 2, 2025 76 

    Domestic Helper insurance may appear to be just another compliance task for employers in Singapore,...

    One Stock, Many Prices: Understanding US Markets

    Published on Aug 26, 2025 274 

    Why Isn’t My Order Filled at the Price I See? Have you ever set a...

    Why Every Investor Should Understand Put Selling

    Published on Aug 26, 2025 116 

    Introduction Options trading can seem complicated at first, but it offers investors flexible strategies to...

    Mastering Stop-Loss Placement: A Guide to Profitability in Forex Trading

    Published on Aug 19, 2025 129 

    Effective stop-loss placement is a cornerstone of prudent risk management in forex trading. It’s not...

    Boosting ETF Portfolio Efficiency: Reducing Tax Leakage Through Smarter ETF Selection

    Published on Aug 15, 2025 198 

    Introduction: Why Tax Efficiency Matters in Global ETF Investing Diversification is the foundation of a...

    How to Build a Diversified Global ETF Portfolio

    Published on Aug 15, 2025 112 

    Introduction: Why Diversification Is Essential in 2025 In our June edition article (https://www.poems.com.sg/market-journal/the-complete-etf-playbook-for-singapore-investors-from-beginner-to-advanced-strategies/), we introduced...

    Contact us to Open an Account

    Need Assistance? Share your Details and we’ll get back to you

    IMPORTANT INFORMATION

    This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

    An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

    Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

    Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

    The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

    The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

    The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

    This advertisement has not been reviewed by the Monetary Authority of Singapore.  

     

    Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
    250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
    Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com